These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7929873)

  • 41. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
    Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C
    Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia.
    Zuck P; Rio Y; Ichou F
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():71-7. PubMed ID: 2292534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study of the bactericidal effect of cefpodoxime using an in vitro pharmacokinetic model].
    Caisson A; Chantot JF
    Pathol Biol (Paris); 1991 Oct; 39(8):774-9. PubMed ID: 1762835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children.
    Bairamis TN; Nikolopoulos TP; Kafetzis DA; Begue P; Lenfant B; Kandiloros DC; Apostolopoulos NJ
    J Antimicrob Chemother; 1996 Apr; 37(4):821-4. PubMed ID: 8722549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
    Asmar BI; Dajani AS; Del Beccaro MA; Mendelman PM
    Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.
    Blouin RA; Kneer J; Stoeckel K
    Antimicrob Agents Chemother; 1989 Mar; 33(3):291-6. PubMed ID: 2729925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbiological evaluation of cefpodoxime proxetil.
    Wiedemann B; Luhmer E; Zühlsdorf MT
    Drugs; 1991; 42 Suppl 3():6-12. PubMed ID: 1726210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.
    Baldwin DR; Wise R; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1992 Jul; 30(1):67-71. PubMed ID: 1429338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora.
    Brismar B; Edlund C; Nord CE
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):714-9. PubMed ID: 8243490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interstitial tissue concentrations of cefpodoxime.
    Liu P; Müller M; Grant M; Webb AI; Obermann B; Derendorf H
    J Antimicrob Chemother; 2002 Jul; 50 Suppl():19-22. PubMed ID: 12077156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
    Toyonaga Y; Koizumi M; Imai H; Sugita M; Takahashi T; Fukushima Y; Yamasaki M; Hori M
    Jpn J Antibiot; 1989 Jul; 42(7):1519-46. PubMed ID: 2810728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis.
    Gehanno P; Depondt J; Barry B; Simonet M; Dewever H
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():87-91. PubMed ID: 2127269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous spectrophotometric determination of Cefpodoxime proxetil and Potassium clavulanate.
    Gandhi SV; Patil UP; Patil NG
    Hindustan Antibiot Bull; 2009; 51(1-4):24-8. PubMed ID: 21268556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cefpodoxime proxetil concentrations in head and neck tissues.
    Theopold HM; Matthias C; Adam D
    Infection; 1991; 19(1):41-3. PubMed ID: 2013507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparative trial of the clinical efficacy and tolerance of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in superinfections of chronic obstructive bronchopneumopathies in adults in urban practice].
    Brambilla C; Benhamou D; Guérin JC; Kelkel E; Muir JF; Prud'homme A; Taytard A; Fauche A
    Pathol Biol (Paris); 1995 Nov; 43(9):815-24. PubMed ID: 8746104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cefpodoxime: pharmacokinetics and therapeutic uses.
    Chugh K; Agrawal S
    Indian J Pediatr; 2003 Mar; 70(3):227-31. PubMed ID: 12785294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults.
    Phillips H; Van Hook CJ; Butler T; Todd WM
    Chest; 1993 Nov; 104(5):1387-92. PubMed ID: 8222793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penetration of cefpodoxime into uterine and vaginal secretions from postpartum women after a single oral dose of cefpodoxime proxetil.
    Takasugi N; Tsunaga N; Sugino N; Numa F; Kato H
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1832-4. PubMed ID: 8843289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.